Delivery Order SPE2DR25D1102-SPE2DR26FFB0S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NESACAINE-MPF 3% Vial 20ML with a ceiling value of $1,424.95 under a firm fixed price contract type. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, Corporate Office Division, a for-profit pharmaceutical distributor. The contract is for the delivery of NESACAINE-MPF 3% VIAL 20ML, a local anesthetic medication, with a ceiling value of $1,426.07 and a completion date of July 17, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation. AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NESACAINE-MPF 3% VIAL 20ML, a pharmaceutical product, with a ceiling value of $1,618.08 and a period of performance ending on April 1, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
- The Defense Logistics Agency (DLA) awarded a $2,179.83 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Sensorcaine-MPF 0.5% in 30 mL vials. This is a firm fixed-price contract with an ultimate completion date of October 29, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded through open competition. This delivery...
- This delivery order, valued at $5,894.97, was awarded on January 6, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency to support pharmaceutical procurement needs. The award is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations, and the contract has an...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $45,863.28 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger Indefinite Delivery Contract vehicle and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $82,863 to AmerisourceBergen Drug Corp on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's parent company, Cencora, Inc., and was competitively awarded with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,128.73 to AmerisourceBergen Drug Corp on January 7, 2026, for pharmaceutical products and services. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award represents a task order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,379.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 20, 2025, with completion scheduled for November 21, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency Medical Supply Chain awarded a $11,415 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on January 6, 2026, with completion targeted for January 7, 2026. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The award was made on a fully competitive, non-set-aside basis to AmerisourceBergen's Corporate Office division...
- SPE2DR25D1102Indefinite Delivery Contract
- SPE2DR25D1102-SPE2DR26FFB0SDelivery Order
The Defense Logistics Agency awarded a $5,475 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Nesacaine-MPF 3% vials (20 mL) under a firm fixed-price contract structure. The award is non-competitive with no set-aside designation and is scheduled for completion by January 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of parent company Cencora, Inc., which is a major pharmaceutical distributor serving federal government healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999 through December 2026. This comprehensive IDC enables the contractor to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and other medical commodities distributed through the Defense Health Agency and related government healthcare systems. AmerisourceBergen's consistent receipt of non-set-aside, competitively awarded contracts demonstrates its established capability to meet federal medical procurement requirements for the Department of Defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 1/7/26 |